Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery (2016)
- Authors:
- USP affiliated authors: SERAFINI, LUCIANO NEDER - FMRP ; SQUIRE, JEREMY ANDREW - FMRP
- Unidade: FMRP
- DOI: 10.1586/14789450.2016.1165613
- Subjects: NEOPLASIAS OVARIANAS; BIOMARCADORES; IMUNOTERAPIA
- Keywords: Extracellular vesicles; Biomarkers; Exosomes; Glycoproteins; Immunotherapy; Matrix metalloproteinase; MicroRNAs; Ovarian cancer
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Expert Review of Proteomics
- ISSN: 1478-9450
- Volume/Número/Paginação/Ano: v. 13, n. 4, p. 395-409, 2016
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
NAWAZ, Muhammad et al. Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery. Expert Review of Proteomics, v. 13, n. 4, p. 395-409, 2016Tradução . . Disponível em: https://doi.org/10.1586/14789450.2016.1165613. Acesso em: 19 set. 2024. -
APA
Nawaz, M., Fatima, F., Nazarenko, I., Ekström, K., Murtaza, I., Anees, M., et al. (2016). Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery. Expert Review of Proteomics, 13( 4), 395-409. doi:10.1586/14789450.2016.1165613 -
NLM
Nawaz M, Fatima F, Nazarenko I, Ekström K, Murtaza I, Anees M, Sultan A, Neder L, Camussi G, Valadi H, Squire JA, Kislinger T. Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery [Internet]. Expert Review of Proteomics. 2016 ; 13( 4): 395-409.[citado 2024 set. 19 ] Available from: https://doi.org/10.1586/14789450.2016.1165613 -
Vancouver
Nawaz M, Fatima F, Nazarenko I, Ekström K, Murtaza I, Anees M, Sultan A, Neder L, Camussi G, Valadi H, Squire JA, Kislinger T. Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery [Internet]. Expert Review of Proteomics. 2016 ; 13( 4): 395-409.[citado 2024 set. 19 ] Available from: https://doi.org/10.1586/14789450.2016.1165613 - Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- Extracellular vesicles: evolving factors in stem cell biology
- The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation
- In silico shows that PTEN loss and AR overexpression are associated with increased CD8+ T-cell and Treg density and earlier disease recurrence in prostate cancer
- Clinical implications of PTEN loss in prostate cancer
- A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
- First application of the Automated QUantitative Analysis (AQUA) technique to quantify PTEN protein expression in ovarian cancer: a correlative study of NCIC CTG OV.16
Informações sobre o DOI: 10.1586/14789450.2016.1165613 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
